12/10
07:17 am
amph
Amphastar Pharmaceuticals (NASDAQ:AMPH) was upgraded by analysts at Barclays PLC to a "hold" rating.
Low
Report
Amphastar Pharmaceuticals (NASDAQ:AMPH) was upgraded by analysts at Barclays PLC to a "hold" rating.
12/9
10:20 am
amph
Rating for AMPH
Low
Report
Rating for AMPH
12/9
10:20 am
amph
Rating for AMPH
Low
Report
Rating for AMPH
12/9
09:06 am
amph
Amphastar Pharmaceuticals (NASDAQ:AMPH) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $30.00 price target on the stock.
Low
Report
Amphastar Pharmaceuticals (NASDAQ:AMPH) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $30.00 price target on the stock.
12/8
04:25 pm
amph
Amphastar initiated with an Equal Weight at Barclays
Low
Report
Amphastar initiated with an Equal Weight at Barclays
12/8
04:25 pm
amph
Amphastar initiated with an Equal Weight at Barclays
Low
Report
Amphastar initiated with an Equal Weight at Barclays
11/7
05:02 am
amph
Rating for AMPH
Medium
Report
Rating for AMPH
11/7
05:02 am
amph
Rating for AMPH
Medium
Report
Rating for AMPH
10/22
08:04 am
amph
Amphastar Pharmaceuticals (NASDAQ:AMPH) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock.
High
Report
Amphastar Pharmaceuticals (NASDAQ:AMPH) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock.
10/22
06:50 am
amph
Rating for AMPH
Low
Report
Rating for AMPH
10/22
06:50 am
amph
Rating for AMPH
Low
Report
Rating for AMPH